Log In
Print this Print this

Staphylococcus aureus vaccine

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionMultivalent glycoprotein vaccine composed of S. aureus capsular polysaccharides conjugated to S. aureus protein antigens
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationStaphylococcus
Indication DetailsVaccinate against Staphylococcus aureus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today